GMPs, or 'Good Manufacturing Practices', are a set of practices which are necessary in order for a product to conform to the guidelines of various regulatory agencies around the world. GMPs mainly affect pharmaceutical products, tobacco products, cosmetics, and foods. These practices were implemented so...
Studies have demonstrated CBD’s proficiency to treat inflammation with the ability to remedy a number of physical and mental illnesses. Compounds with anti-inflammatory properties are highly prized in both wellness and medical markets, and CBD has the added benefits of antibacterial and antiviral attributes. With the popularity of tinctures, topicals and capsules promoting increased consumer accessibility and adoption, the global CBD market is expected to surpass $13 billion in revenue by 2028. The EU cosmetic ingredient database determined that cannabinoids can be used in cleansers and conditioners, with hemp-based CBD oil particularly revered as it rejuvenates damaged skin.
Industry-leading cannabinoid extractor enhances offerings with white label solutions
Following the groundbreaking success of Vantage Hemp Co. in the cannabinoid industry, the company has announced the expansion of its contract manufacturing services to include a white labeling program. The only North American hemp processor with both ICH Q7 and WHO Good Manufacturing Practices (GMP) certified facilities, Vantage Hemp is one of the highest accredited cannabinoid extractors in the world, which enables Vantage Hemp and its partners to export pharmaceutical-grade CBD products internationally.